PK-Directed Intravenous Busulfan in Combination with High-Dose Melphalan and Bortezomib As Conditioning Regimen for Patients with Multiple Myeloma

被引：1

作者：

Barta, Stefan Klaus ^{[1
]}

Mazumder, Amitabha ^{[2
]}

Carter, Jason ^{[1
]}

Almanzar, Lawrence ^{[1
]}

Elkind, Richard ^{[1
]}

Battini, Ramakrishna ^{[1
]}

Derman, Olga ^{[1
]}

Kornblum, Noah ^{[1
]}

Xue, Xionan ^{[3
]}

Verma, Amit ^{[1
]}

Braunschweig, Ira ^{[1
]}

机构：

[1] Montefiore Med Ctr, Bronx, NY 10467 USA

[2] NYU Canc Ctr, New York, NY USA

[3] Albert Einstein Canc Ctr, Bronx, NY USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期

关键词：

D O I：

10.1016/j.bbmt.2013.12.146

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

126

引用

页码：S104 / S105

页数：2

共 50 条

[31] Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) [J].

Mihee Kim ;

Je-Jung Lee ;

Chang-Ki Min ;

Ji Yun Lee ;

Jae-Cheol Jo ;

Sung-Soo Yoon ;

Sung-Nam Lim ;

Young Rok Do ;

Kihyun Kim ;

Jae Hoon Lee ;

Kwai Han Yoo ;

Sung Hwa Bae ;

Jun Ho Yi ;

Jongheon Jung ;

Hyeon-Seok Eom ;

Sung-Hoon Jung .

Annals of Hematology, 2023, 102 :2233-2240

[32] Bortezomib and high-dose melphalan as conditioning regimen before transplantation for de novo multiple myeloma patients: Updated data of the IFM phase II study [J].

Roussel, M. ;

Moreau, P. ;

Huynh, A. ;

Mary, J. ;

Caillot, D. ;

Hullin, C. ;

Mathiot, C. ;

Avet-Loiseau, H. ;

Harousseau, J. ;

Attal, M. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)

[33] Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen [J].

Hagen, Patrick ;

D'Souza, Anita ;

Hari, Parameswaran ;

Davila, Omar ;

Zhang, Mei-Jie ;

Vesole, David H. ;

Smith, Scott E. ;

Rodriguez, Tulio E. ;

Stiff, Patrick J. .

LEUKEMIA & LYMPHOMA, 2020, 61 (14) :3484-3492

[34] MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE INTRAVENOUS MELPHALAN [J].

SELBY, PJ ;

MCELWAIN, TJ ;

NANDI, AC ;

PERREN, TJ ;

POWLES, RL ;

TILLYER, CR ;

OSBORNE, RJ ;

SLEVIN, ML ;

MALPAS, JS .

BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (01) :55-62

[35] BORTEZOMIB, LOW DOSE INTRAVENOUS MELPHALAN AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED MULTIPLE MYELOMA [J].

Popat, R. ;

Oakervee, H. ;

Williams, C. ;

Cook, M. ;

Craddock, C. ;

Basu, S. ;

Singer, C. ;

Odeh, L. ;

Foot, N. ;

Joel, S. ;

Hallam, S. ;

Harding, S. ;

Mead, G. ;

Cavenagh, J. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 :365-366

[36] Low dose intravenous melphalan and bortezomib for relapsed multiple myeloma [J].

Popat, R ;

Oakervee, HE ;

Foot, N ;

Agrawal, S ;

Odeh, L ;

Craddock, C ;

Williams, C ;

Basu, S ;

Williams, C ;

Basu, S ;

Cavenagh, JD .

BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 :98-98

[37] Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial [J].

Blanes, Margarita ;

de la Rubia, Javier ;

Lahuerta, Juan J. ;

Gonzalez, Jose D. ;

Ribas, Paz ;

Solano, Carlos ;

Alegre, Adrian ;

Sanz, Miguel A. .

LEUKEMIA & LYMPHOMA, 2009, 50 (02) :216-222

[38] Toxicity and early response after single daily dose of intravenous busulfan and melphalan as conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma [J].

de la Rubia, J. ;

Lahuerta, J. J. ;

Gonzalez, J. D. ;

Ribas, P. ;

Solano, C. ;

Sanz, M. A. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06) :192-192

[39] Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients [J].

Dalla Palma, Benedetta ;

Accardi, Fabrizio ;

Prezioso, Lucia ;

Notarfranchi, Laura ;

Giuliani, Nicola .

LEUKEMIA & LYMPHOMA, 2020, 61 (05) :1238-1241

[40] Bortezomib, Dexamethasone, and High-Dose Melphalan as Conditioning for Stem Cell Transplantation in Young Japanese Multiple Myeloma Patients: A Pilot Study [J].

Naoki Takezako ;

Naohiro Sekiguchi ;

Akihisa Nagata ;

Chiho Homma ;

Satoshi Noto ;

Akiyoshi Miwa .

Indian Journal of Hematology and Blood Transfusion, 2013, 29 :147-151

← 1 2 3 4 5 →